XSHC:LSE:LSE-Xtrackers MSCI USA Health Care UCITS ETF 1D (GBX)

ETF | Others |

Last Closing

USD 4675.25

Change

+12.25 (+0.26)%

Market Cap

USD 0.67B

Volume

1.39K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.00 (-2.15%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.37 (+3.69%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.57%)

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.11 (-0.59%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.45 (-0.64%)

USD 266.08B
0QZO:LSE 0QZO

-0.45 (-0.48%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.19 (-0.60%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

-1.12 (-0.67%)

USD 202.26B
0R24:LSE Intel Corp.

-0.67 (-2.92%)

USD 196.14B

ETFs Containing XSHC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.88% 53% F 57% F
Dividend Return 0.01% 13% F 18% F
Total Return 7.89% 51% F 56% F
Trailing 12 Months  
Capital Gain 10.32% 34% F 43% F
Dividend Return 0.01% 13% F 15% F
Total Return 10.34% 32% F 42% F
Trailing 5 Years  
Capital Gain 61.59% 73% C 78% C+
Dividend Return 0.03% 10% F 10% F
Total Return 61.62% 72% C 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 9.78% N/A N/A 69% C-
Dividend Return 9.78% N/A N/A 68% D+
Total Return 0.00% N/A N/A 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 8.37% N/A N/A 85% B
Risk Adjusted Return 116.92% N/A N/A 99% N/A
Market Capitalization 0.67B 78% C+ 46% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike